Skip header and navigation

2 records – page 1 of 1.

Acute hemodialysis

https://libcat.nshealth.ca/en/permalink/chpams35036
Nova Scotia Health Authority. QEII. Nephrology Services. Halifax, NS: Nova Scotia Health Authority , 2017.
Pamphlet Number
1151
Available Online
View Pamphlet
Dialysis is a life-saving treatment which takes away waste and extra water from the blood. This pamphlet discusses why your kidneys are important and how you will feel if waste products build up in your blood. It defines acute kidney failure, dialysis, and hemodialysis. It discusses how long, and how often the treatment is needed and the special catheters needed for the treatment. Challenges for those living with kidney disease, resources available, as well as instructions for follow-up care ar…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. QEII. Nephrology Services
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2017
Format
Pamphlet
Language
English
Physical Description
1 electronic document (5 p.) : digital, PDF file
Subjects (MeSH)
Renal Dialysis
Acute Kidney Injury
Kidney Diseases - therapy
Subjects (LCSH)
Hemodialysis
Acute renal failure
Abstract
Dialysis is a life-saving treatment which takes away waste and extra water from the blood. This pamphlet discusses why your kidneys are important and how you will feel if waste products build up in your blood. It defines acute kidney failure, dialysis, and hemodialysis. It discusses how long, and how often the treatment is needed and the special catheters needed for the treatment. Challenges for those living with kidney disease, resources available, as well as instructions for follow-up care are given.
Responsibility
Prepared by: Nephrology Services
Pamphlet Number
1151
Less detail

Adalimumab therapy for inflammatory bowel disease (IBD)

https://libcat.nshealth.ca/en/permalink/chpams35127
Nova Scotia Health Authority. Nova Scotia Collaborative IBD Program. Halifax, NS: Nova Scotia Health Authority , 2022.
Pamphlet Number
1207
Available Online
View Pamphlet
Your health care provider feels that treatment with adalimumab may help you manage your inflammatory bowel disease (IBD). This pamphlet describes what adalimumab is and some important aspects of therapy with this medication. Precautions and possible side effects are listed.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Nova Scotia Collaborative IBD Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2022
Format
Pamphlet
Language
English
Physical Description
1 electronic document (11 p.) : digital, PDF file
Subjects (MeSH)
Adalimumab
Inflammatory Bowel Diseases - drug therapy
Subjects (LCSH)
Inflammatory bowel diseases
Specialty
Medications
Abstract
Your health care provider feels that treatment with adalimumab may help you manage your inflammatory bowel disease (IBD). This pamphlet describes what adalimumab is and some important aspects of therapy with this medication. Precautions and possible side effects are listed.
Notes
Previous title: Adalimumab (Humira) therapy
Responsibility
Prepared by: Nova Scotia Collaborative IBD Program
Pamphlet Number
1207
Less detail